35261 |
Clinical Neurology; Peripheral Vascular Disease |
Effect of Cognitive Reserve on Risk of Cognitive Impairment and Recove... |
STROKE 2020 10.1161/STROKEAHA.119.026829 |
김연희 |
2020 |
35260 |
Multidisciplinary Sciences |
Determining the cut-off score for the Modified Barthel Index and the M... |
PLoS One 2020 10.1371/journal.pone.0226324 |
김연희 |
2020 |
35259 |
Oncology |
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-La... |
TARGET ONCOL 2020 10.1007/s11523-020-00706-0 |
김승태 |
2020 |
35258 |
Oncology |
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint In... |
TARGET ONCOL 2020 10.1007/s11523-020-00713-1 |
김승태 |
2020 |
35257 |
Oncology |
Claudin 18.2 expression in various tumor types and its role as a poten... |
Transl Cancer Res 2020 10.21037/tcr-19-1876 |
김승태 |
2020 |
35256 |
Oncology |
Antitumor activity and safety of sirolimus for solid tumors with PIK3C... |
Transl Cancer Res 2020 10.21037/tcr.2020.04.07 |
김승태 |
2020 |
35255 |
Oncology |
Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR... |
TARGET ONCOL 2020 10.1007/s11523-019-00691-z |
김승태 |
2020 |
35254 |
Oncology |
Tumor Mutational Burden Determined by Panel Sequencing Predicts Surviv... |
Front Oncol 2020 10.3389/fonc.2020.00314 |
김승태 |
2020 |
35253 |
Oncology |
First-in-human phase I trial of anti-hepatocyte growth factor antibody... |
THER ADV MED ONCOL 2020 10.1177/1758835920926796 |
김승태 |
2020 |
35252 |
Pathology |
TPK1 as a predictive marker for the anti-tumour effects of simvastatin... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152820 |
김승태 |
2020 |